Koichi Kitagawa and associates revealed that Bifidobacterium longum, modified to express Wilms’ tumor 1 (WT1) protein, can elicit tumor-specific immune responses and inhibit tumor proliferation in mouse models of leukemia, prostate, and bladder cancer [27,50,51]. This evidence concerns the gene WT1 and urinary bladder carcinoma.